Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ehrhardt

Showing results (251-260 of 281) with videos related to

Pageof 29
Sort By:
The Lancet. Child & Adolescent Health|September 29, 2022
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupEsmée C de Baat, Elvira C van Dalen, Renée L Mulder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood CancerMatthew J Ehrhardt, Zachary J Ward, Qi Liu, et al.
Pediatric Blood & Cancer|November 19, 2019
Estimated number of adult survivors of childhood cancer in United States with cancer-predisposing germline variantsCarmen L Wilson, Zhaoming Wang, Qi Liu, et al.
CA: a Cancer Journal for Clinicians|January 30, 2018
Factors influencing risk-based care of the childhood cancer survivor in the 21st centuryStephanie B Dixon, Kari L Bjornard, Nicole M Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2025
Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancerK Petrykey, Y Chen, A Neupane, et al.
Cancer|December 26, 2022
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disordersZeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, et al.
Cancer|October 27, 2020
Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime CohortStephanie B Dixon, Carrie R Howell, Lu Lu, et al.
Blood Advances|January 22, 2025
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug eraLianna J Marks, Victor Ritter, Jennifer E Agrusa, et al.
Lancet (London, England)|September 12, 2017
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)Nickhill Bhakta, Qi Liu, Kirsten K Ness, et al.
JACC. Cardiooncology|June 21, 2025
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert PanelTheodorus W Kouwenberg, Elvira C van Dalen, Renée L Mulder, et al.
Pageof 29

Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
The Lancet. Child & Adolescent Health|September 29, 2022
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupEsmée C de Baat, Elvira C van Dalen, Renée L Mulder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood CancerMatthew J Ehrhardt, Zachary J Ward, Qi Liu, et al.
Pediatric Blood & Cancer|November 19, 2019
Estimated number of adult survivors of childhood cancer in United States with cancer-predisposing germline variantsCarmen L Wilson, Zhaoming Wang, Qi Liu, et al.
CA: a Cancer Journal for Clinicians|January 30, 2018
Factors influencing risk-based care of the childhood cancer survivor in the 21st centuryStephanie B Dixon, Kari L Bjornard, Nicole M Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2025
Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancerK Petrykey, Y Chen, A Neupane, et al.
Cancer|December 26, 2022
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disordersZeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, et al.
Cancer|October 27, 2020
Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime CohortStephanie B Dixon, Carrie R Howell, Lu Lu, et al.
Blood Advances|January 22, 2025
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug eraLianna J Marks, Victor Ritter, Jennifer E Agrusa, et al.
Lancet (London, England)|September 12, 2017
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)Nickhill Bhakta, Qi Liu, Kirsten K Ness, et al.
JACC. Cardiooncology|June 21, 2025
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert PanelTheodorus W Kouwenberg, Elvira C van Dalen, Renée L Mulder, et al.
Pageof 29